SCHEMBL28535356

SCHEMBL28535356

Cc1ccc(SC(C#N)c2ccccc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.39
ALDH1A1 P00352 2/20 0.39
TSHR P16473 3/20 0.38
TRPA1 O75762 1/20 0.38
L3MBTL1 Q9Y468 6/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
MAPK1 P28482 1/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
TDP1 Q9NUW8 3/20 0.36
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
HKDC1 Q2TB90 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
LMNA P02545 6/20 0.35
POLB P06746 1/20 0.35
ALOX12 P18054 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11211316 0.83 PTGS1 (0.43) MAPTALDH1A1L3MBTL1SMN1; SMN2CYP1A2
SCHEMBL953114 0.82 MAPT (0.56) MAPTALDH1A1TSHRTRPA1L3MBTL1
SCHEMBL11205005 0.81 ALDH1A1 (0.50) MAPTALDH1A1L3MBTL1SMN1; SMN2MAPK1
SCHEMBL28533184 0.80 L3MBTL1 (0.36) MAPTALDH1A1L3MBTL1MAPK1TDP1
SCHEMBL4796278 0.73 TSHR (0.38) ALDH1A1TSHRTRPA1SMN1; SMN2MAPK1
SCHEMBL8793813 0.73 L3MBTL1 (0.50) MAPTALDH1A1TSHRL3MBTL1SMN1; SMN2
SCHEMBL1709986 0.73 L3MBTL1 (0.50) MAPTALDH1A1TSHRL3MBTL1SMN1; SMN2
SCHEMBL29700321 0.73 L3MBTL1 (0.50) MAPTALDH1A1TSHRL3MBTL1SMN1; SMN2
SCHEMBL9493266 0.72 TSHR (0.46) MAPTALDH1A1TSHRTRPA1L3MBTL1
SCHEMBL28515424 0.72 TSHR (0.50) MAPTALDH1A1TSHRTRPA1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112472699-A Combination methods for improving the therapeutic benefit of bisantrene and derivatives 种族肿瘤学公司 2021-03-12 CN disclosed